• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫组织化学检测铜蓝蛋白鉴别甲状腺滤泡性腺瘤和癌

Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin.

作者信息

Vaideeswar P, Pandit A A, Khilnani P H, Powar H S

机构信息

Department of Pathology, Seth G.S. Medical College, Parel, Bombay.

出版信息

Indian J Pathol Microbiol. 1994 Apr;37(2):165-9.

PMID:7959983
Abstract

In this study, and attempt was made to differentiate between follicular neoplasms of the thyroid using an immunoperoxidase staining technique for detection of ceruloplasmin. 54 histologically proved benign and malignant thyroidal lesions were selected. The staining for ceruloplasmin was consistently positive in follicular carcinoma and negative in follicular adenoma.

摘要

在本研究中,尝试使用免疫过氧化物酶染色技术检测铜蓝蛋白,以鉴别甲状腺滤泡性肿瘤。选取了54例经组织学证实的甲状腺良恶性病变。铜蓝蛋白染色在滤泡癌中始终呈阳性,而在滤泡性腺瘤中呈阴性。

相似文献

1
Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin.通过免疫组织化学检测铜蓝蛋白鉴别甲状腺滤泡性腺瘤和癌
Indian J Pathol Microbiol. 1994 Apr;37(2):165-9.
2
[Immunohistochemical demonstration of ceruloplasmin and lactoferrin in a series of 59 thyroid tumors].[59例甲状腺肿瘤中铜蓝蛋白和乳铁蛋白的免疫组化显示]
Ann Pathol. 1992;12(6):347-52.
3
Immunohistochemistry of thyroid carcinoma--an experience with thyroglobulin and calcitonin.
Indian J Pathol Microbiol. 1998 Apr;41(2):163-7.
4
Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases.甲状腺疾病中表皮生长因子受体和铜蓝蛋白的免疫组织化学显示
Acta Pathol Jpn. 1991 May;41(5):336-43. doi: 10.1111/j.1440-1827.1991.tb01656.x.
5
Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.甲状腺乳头状癌的细针穿刺活检:细胞角蛋白19免疫染色的诊断效用
Cancer. 2000 Oct 25;90(5):307-11.
6
Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.过氧化物酶体增殖物激活受体γ在滤泡型甲状腺病变中的表达。免疫组织化学研究的注意事项。
Am J Clin Pathol. 2003 Aug;120(2):175-81. doi: 10.1309/2E6Q-GJRG-GETV-T8K9.
7
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.高迁移率族蛋白I HMGI(Y)在甲状腺肿瘤诊断中的检测:HMGI(Y)表达是癌的一种潜在诊断指标。
Cancer Res. 1998 Sep 15;58(18):4193-8.
8
Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.半乳糖凝集素-3不能可靠地区分甲状腺良性和恶性肿瘤。
Histopathology. 2004 Nov;45(5):493-500. doi: 10.1111/j.1365-2559.2004.01978.x.
9
Expression of matrix metalloproteinases in benign and malignant follicular thyroid lesions.基质金属蛋白酶在甲状腺滤泡性良恶性病变中的表达
Histopathology. 2006 Feb;48(3):286-94. doi: 10.1111/j.1365-2559.2005.02325.x.
10
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.细胞角蛋白19免疫反应性在甲状腺乳头状癌诊断中的应用:一则警示
Am J Clin Pathol. 2001 Nov;116(5):696-702. doi: 10.1309/6D9D-7JCM-X4T5-NNJY.

引用本文的文献

1
Treatment for benign thyroid nodules with a combination of natural extracts.良性甲状腺结节的自然提取物联合治疗。
Mol Med Rep. 2019 Sep;20(3):2332-2338. doi: 10.3892/mmr.2019.10453. Epub 2019 Jul 1.
2
Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.
Rev Endocr Metab Disord. 2000 Apr;1(3):173-81. doi: 10.1023/a:1010027014324.